Literature DB >> 21504893

DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas.

Ying Gao1, Richard B Hayes, Wen-Yi Huang, Neil E Caporaso, Laurie Burdette, Meredith Yeager, Stephen J Chanock, Sonja I Berndt.   

Abstract

DNA damage is thought to play a critical role in the development of colorectal adenoma. Variation in DNA repair genes may alter their capacity to correct endogenous and exogenous DNA damage. We explored the association between common single-nucleotide polymorphisms (SNPs) in DNA repair genes and adenoma risk with a case-control study nested in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. A total of 1338 left sided, advanced colorectal adenoma cases and 1503 matched controls free of left-sided polyps were included in the study. Using DNA extracted from blood, 3144 tag SNPs in 149 DNA repair genes were successfully genotyped. Among Caucasians, 30 SNPs were associated with adenoma risk at P < 0.01, with four SNPs remaining significant after gene-based adjustment for multiple testing. The most significant finding was for a non-synonymous SNP (rs9350) in Exonuclease-1 (EXO1) [odds ratio (OR) = 1.30, 95% confidence interval (CI) = 1.11-1.51, P = 0.001)], which was predicted to be damaging using bioinformatics methods. However, the association was limited to smokers with a strong risk for current smokers (OR = 2.15, 95% CI = 1.27-3.65) and an intermediate risk for former smokers (OR = 1.45, 95% CI = 1.14-1.82) and no association for never smokers (OR = 0.98, 95% CI = 0.76-1.25) (P(interaction) = 0.002). Among the top findings, an SNP (rs17503908) in ataxia telangiectasia mutated (ATM) was inversely related to adenoma risk (OR = 0.75, 95% CI = 0.63-0.91). The association was restricted to never smokers (OR = 0.55, 95% CI = 0.40-0.76) with no increased risk observed among smokers (OR = 0.89, 95% CI = 0.70-1.13) (P(interaction) = 0.006). This large comprehensive study, which evaluated all presently known DNA repair genes, suggests that polymorphisms in EXO1 and ATM may be associated with risk for advanced colorectal adenoma with the associations modified by tobacco-smoking status.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21504893      PMCID: PMC3106441          DOI: 10.1093/carcin/bgr071

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  56 in total

Review 1.  Inherited susceptibility to common cancers.

Authors:  William D Foulkes
Journal:  N Engl J Med       Date:  2008-11-13       Impact factor: 91.245

2.  Influence of cancer-related gene polymorphisms on clinicopathological features in colorectal cancer.

Authors:  Gen Yoshiya; Takenori Takahata; Naoyuki Hanada; Kazuhiro Suzuki; Atsushi Ishiguro; Masato Saito; Mutsuo Sasaki; Shinsaku Fukuda
Journal:  J Gastroenterol Hepatol       Date:  2008-01-19       Impact factor: 4.029

3.  The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence.

Authors:  Rachel R Huxley; Alireza Ansary-Moghaddam; Peter Clifton; Sebastien Czernichow; Christine L Parr; Mark Woodward
Journal:  Int J Cancer       Date:  2009-07-01       Impact factor: 7.396

4.  Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.

Authors:  Patrick Concannon; Robert W Haile; Anne-Lise Børresen-Dale; Barry S Rosenstein; Richard A Gatti; Sharon N Teraoka; T Anh Diep; Laila Jansen; David P Atencio; Bryan Langholz; Marinela Capanu; Xiaolin Liang; Colin B Begg; Duncan C Thomas; Leslie Bernstein; Jørgen H Olsen; Kathleen E Malone; Charles F Lynch; Hoda Anton-Culver; Jonine L Bernstein
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

5.  Potentially functional polymorphisms of EXO1 and risk of lung cancer in a Chinese population: A case-control analysis.

Authors:  Guangfu Jin; Haifeng Wang; Zhibin Hu; Hongliang Liu; Weiwei Sun; Hongxia Ma; Dan Chen; Ruifen Miao; Tian Tian; Li Jin; Qingyi Wei; Wei Huang; Daru Lu; Hongbing Shen
Journal:  Lung Cancer       Date:  2008-02-20       Impact factor: 5.705

6.  Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors.

Authors:  P T Campbell; K Curtin; C M Ulrich; W S Samowitz; J Bigler; C M Velicer; B Caan; J D Potter; M L Slattery
Journal:  Gut       Date:  2008-06-03       Impact factor: 23.059

7.  The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer.

Authors:  Wade S Samowitz; Karen Curtin; Roger K Wolff; Hans Albertsen; Carol Sweeney; Bette J Caan; Cornelia M Ulrich; John D Potter; Martha L Slattery
Journal:  Genes Chromosomes Cancer       Date:  2008-10       Impact factor: 5.006

8.  Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis.

Authors:  Maartje Nielsen; Mirjam C Joerink-van de Beld; Natalie Jones; Stefanie Vogt; Carli M Tops; Hans F A Vasen; Julian R Sampson; Stefan Aretz; Frederik J Hes
Journal:  Gastroenterology       Date:  2008-10-30       Impact factor: 22.682

9.  Cigarette smoking and adenomatous polyps: a meta-analysis.

Authors:  Edoardo Botteri; Simona Iodice; Sara Raimondi; Patrick Maisonneuve; Albert B Lowenfels
Journal:  Gastroenterology       Date:  2007-11-04       Impact factor: 22.682

10.  Lung cancer susceptibility and genetic polymorphisms of Exo1 gene in Taiwan.

Authors:  Nan-Yung Hsu; Hwei-Chung Wang; Chung-Hsing Wang; Chang-Fang Chiu; Hsien-Chang Tseng; Shiu-Yun Liang; Chia-Wen Tsai; Cheng-Chieh Lin; Da-Tian Bau
Journal:  Anticancer Res       Date:  2009-02       Impact factor: 2.480

View more
  14 in total

1.  Association between ATM polymorphisms and cancer risk: a meta-analysis.

Authors:  Li Shen; Zhi-Hua Yin; Yan Wan; Yue Zhang; Kun Li; Bao-Sen Zhou
Journal:  Mol Biol Rep       Date:  2011-12-28       Impact factor: 2.316

2.  Exonuclease 1 (EXO1) gene variation and melanoma risk.

Authors:  Fengju Song; Abrar A Qureshi; Jiangwen Zhang; Jiangwen Zhan; Christopher I Amos; Jeffrey E Lee; Qingyi Wei; Jiali Han
Journal:  DNA Repair (Amst)       Date:  2012-01-09

Review 3.  Understanding specific functions of PARP-2: new lessons for cancer therapy.

Authors:  Syed O Ali; Farhaan A Khan; Miguel A Galindo-Campos; José Yélamos
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

4.  Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer.

Authors:  E J Kap; P Seibold; S Richter; D Scherer; N Habermann; Y Balavarca; L Jansen; N Becker; K Pfütze; O Popanda; M Hoffmeister; A Ulrich; A Benner; C M Ulrich; B Burwinkel; H Brenner; J Chang-Claude
Journal:  Pharmacogenomics J       Date:  2015-03-17       Impact factor: 3.550

5.  Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma.

Authors:  Zi-Zhen Zhang; Yuan Jie Charles Liu; Xiao-Lu Yin; Ping Zhan; Yi Gu; Xing-Zhi Ni
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

6.  Genetic variation in the base excision repair pathway, environmental risk factors, and colorectal adenoma risk.

Authors:  Roman Corral; Juan Pablo Lewinger; Amit D Joshi; A Joan Levine; David J Vandenberg; Robert W Haile; Mariana C Stern
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

7.  Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways.

Authors:  Lisette Stolk; John R B Perry; Daniel I Chasman; Chunyan He; Massimo Mangino; Patrick Sulem; Maja Barbalic; Linda Broer; Enda M Byrne; Florian Ernst; Tõnu Esko; Nora Franceschini; Daniel F Gudbjartsson; Jouke-Jan Hottenga; Peter Kraft; Patrick F McArdle; Eleonora Porcu; So-Youn Shin; Albert V Smith; Sophie van Wingerden; Guangju Zhai; Wei V Zhuang; Eva Albrecht; Behrooz Z Alizadeh; Thor Aspelund; Stefania Bandinelli; Lovorka Barac Lauc; Jacques S Beckmann; Mladen Boban; Eric Boerwinkle; Frank J Broekmans; Andrea Burri; Harry Campbell; Stephen J Chanock; Constance Chen; Marilyn C Cornelis; Tanguy Corre; Andrea D Coviello; Pio d'Adamo; Gail Davies; Ulf de Faire; Eco J C de Geus; Ian J Deary; George V Z Dedoussis; Panagiotis Deloukas; Shah Ebrahim; Gudny Eiriksdottir; Valur Emilsson; Johan G Eriksson; Bart C J M Fauser; Liana Ferreli; Luigi Ferrucci; Krista Fischer; Aaron R Folsom; Melissa E Garcia; Paolo Gasparini; Christian Gieger; Nicole Glazer; Diederick E Grobbee; Per Hall; Toomas Haller; Susan E Hankinson; Merli Hass; Caroline Hayward; Andrew C Heath; Albert Hofman; Erik Ingelsson; A Cecile J W Janssens; Andrew D Johnson; David Karasik; Sharon L R Kardia; Jules Keyzer; Douglas P Kiel; Ivana Kolcic; Zoltán Kutalik; Jari Lahti; Sandra Lai; Triin Laisk; Joop S E Laven; Debbie A Lawlor; Jianjun Liu; Lorna M Lopez; Yvonne V Louwers; Patrik K E Magnusson; Mara Marongiu; Nicholas G Martin; Irena Martinovic Klaric; Corrado Masciullo; Barbara McKnight; Sarah E Medland; David Melzer; Vincent Mooser; Pau Navarro; Anne B Newman; Dale R Nyholt; N Charlotte Onland-Moret; Aarno Palotie; Guillaume Paré; Alex N Parker; Nancy L Pedersen; Petra H M Peeters; Giorgio Pistis; Andrew S Plump; Ozren Polasek; Victor J M Pop; Bruce M Psaty; Katri Räikkönen; Emil Rehnberg; Jerome I Rotter; Igor Rudan; Cinzia Sala; Andres Salumets; Angelo Scuteri; Andrew Singleton; Jennifer A Smith; Harold Snieder; Nicole Soranzo; Simon N Stacey; John M Starr; Maria G Stathopoulou; Kathleen Stirrups; Ronald P Stolk; Unnur Styrkarsdottir; Yan V Sun; Albert Tenesa; Barbara Thorand; Daniela Toniolo; Laufey Tryggvadottir; Kim Tsui; Sheila Ulivi; Rob M van Dam; Yvonne T van der Schouw; Carla H van Gils; Peter van Nierop; Jacqueline M Vink; Peter M Visscher; Marlies Voorhuis; Gérard Waeber; Henri Wallaschofski; H Erich Wichmann; Elisabeth Widen; Colette J M Wijnands-van Gent; Gonneke Willemsen; James F Wilson; Bruce H R Wolffenbuttel; Alan F Wright; Laura M Yerges-Armstrong; Tatijana Zemunik; Lina Zgaga; M Carola Zillikens; Marek Zygmunt; Alice M Arnold; Dorret I Boomsma; Julie E Buring; Laura Crisponi; Ellen W Demerath; Vilmundur Gudnason; Tamara B Harris; Frank B Hu; David J Hunter; Lenore J Launer; Andres Metspalu; Grant W Montgomery; Ben A Oostra; Paul M Ridker; Serena Sanna; David Schlessinger; Tim D Spector; Kari Stefansson; Elizabeth A Streeten; Unnur Thorsteinsdottir; Manuela Uda; André G Uitterlinden; Cornelia M van Duijn; Henry Völzke; Anna Murray; Joanne M Murabito; Jenny A Visser; Kathryn L Lunetta
Journal:  Nat Genet       Date:  2012-01-22       Impact factor: 38.330

8.  Prognostic Significance of Nuclear Phospho-ATM Expression in Melanoma.

Authors:  Madhuri Bhandaru; Magdalena Martinka; Kevin J McElwee; Anand Rotte
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

9.  What's your poison? Impact of individual repair capacity on the outcomes of genotoxic therapies in cancer. Part II - information content and validity of biomarkers for individual repair capacity in the assessment of outcomes of anticancer therapy.

Authors:  Rumena Petkova; Pavlina Chelenkova; Elena Georgieva; Stoian Chakarov
Journal:  Biotechnol Biotechnol Equip       Date:  2014-01-02       Impact factor: 1.632

10.  Common genetic variants in the 9p21 region and their associations with multiple tumours.

Authors:  F Gu; R M Pfeiffer; S Bhattacharjee; S S Han; P R Taylor; S Berndt; H Yang; A J Sigurdson; J Toro; L Mirabello; M H Greene; N D Freedman; C C Abnet; S M Dawsey; N Hu; Y-L Qiao; T Ding; A V Brenner; M Garcia-Closas; R Hayes; L A Brinton; J Lissowska; N Wentzensen; C Kratz; L E Moore; R G Ziegler; W-H Chow; S A Savage; L Burdette; M Yeager; S J Chanock; N Chatterjee; M A Tucker; A M Goldstein; X R Yang
Journal:  Br J Cancer       Date:  2013-01-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.